[HTML][HTML] Beyond Immunosuppression: The Intricate Relationship Between Tacrolimus and Microangiopathy
RS Munjal, J Sharma, S Polishetti, PS Valleru… - Cureus, 2023 - ncbi.nlm.nih.gov
Tacrolimus, widely known as Prograf, has become the preferred immunosuppressant for
preventing graft rejection in solid organ transplant recipients, particularly in steroid-sparing …
preventing graft rejection in solid organ transplant recipients, particularly in steroid-sparing …
Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system
Y Lu, Q Xu, S Zhu - Frontiers in Pharmacology, 2024 - frontiersin.org
Background This study aims to investigate adverse drug reaction signals associated with
coagulopathies through data mining using the Adverse Event Reporting System (FAERS) of …
coagulopathies through data mining using the Adverse Event Reporting System (FAERS) of …
Tacrolimus-induced thrombotic microangiopathy (TMA) after heart and lung transplantation successfully treated with eculizumab
Z Kattih, A Iacono, C Saikus, M Esposito, Z Kon… - Transplant …, 2024 - Elsevier
Introduction Tacrolimus-induced thrombotic microangiopathy (TMA) causing acute kidney
injury (AKI) without systemic features is a rare entity, particularly after non-renal solid organ …
injury (AKI) without systemic features is a rare entity, particularly after non-renal solid organ …